[1] |
Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021, 19:329-359.
|
[2] |
Esmeeta A, Adhikary S, Dharshnaa V, et al. Plant-derived bioactive compounds in colon cancer treatment: an updated review[J]. Biomed Pharmacother, 2022, 153:113384-113396.
|
[3] |
代珊, 刘匡飞. 桂枝茯苓丸加减方辅治晚期卵巢癌的临床效果与安全性[J]. 临床合理用药杂志, 2021, 14:145-147.
|
[4] |
方丽, 朱晓丹, 鲍静, 等. 中药饮片治疗乳腺癌的用药规律[J]. 世界中医药, 2022, 17:1765-1768.
|
[5] |
樊燕青, 孙兰池, 李大鹏. 茯苓酸对舌鳞状细胞癌细胞CAL-27增殖,凋亡及细胞周期的影响[J]. 中成药, 2021, 43:1909-1914.
|
[6] |
Sun KX, Xia HW. Pachymic acid inhibits growth and induces cell cycle arrest and apoptosis in gastric cancer SGC-7901 cells[J]. Oncol Lett, 2018, 16:2517-2524.
|
[7] |
Jiang Y, Fan L. Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: in vivo and in vitro, identification and mechanism[J]. J Ethnopharmacol, 2020, 257:112851-112899.
|
[8] |
Jiang F, Zhu T, Yang C, et al. Pachymic acid inhibits growth and metastatic potential in liver cancer HepG2 and Huh7 cells[J]. Biol Pharm Bull, 2023, 46:35-41.
|
[9] |
Subramaniam D, Angulo P, Ponnurangam S, et al. Suppressing STAT5 signaling affects osteosarcoma growth and stemness[J]. Cell Death Dis, 2020, 11:149-164.
|
[10] |
Permatasari HK, Wewengkang DS, Tertiana NI, et al. Anti-cancer properties of Caulerpa racemosa by altering expression of Bcl-2, BAX, cleaved caspase 3 and apoptosis in HeLa cancer cell culture[J]. Front Oncol, 2022, 12:964816-964827.
|
[11] |
冯振宇, 孟霜, 马小娟, 等. 马钱子碱对人结肠癌HT-29细胞增殖,细胞周期的影响及其作用机制[J]. 中华中医药杂志, 2021, 36:2359-2362.
|
[12] |
Hashem S, Nisar S, Sageena G, et al. Therapeutic effects of curcumol in several diseases; an overview[J]. Nutr Cancer, 2021, 73:181-195.
|
[13] |
Zhao Y, Cai J, Shi K, et al. Germacrone induces lung cancer cell apoptosis and cell cycle arrest via the Akt/MDM2/p53 signaling pathway[J]. Mol Med Rep, 2021, 23:452-461.
|
[14] |
Wei C, Du J, Shen Y, et al. Anticancer effect of involucrasin A on colorectal cancer cells by modulating the Akt/MDM2/p53 pathway[J]. Oncol Lett, 2023, 25:218-229.
|
[15] |
Qi J, Li J, Bie B, et al. miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10[J]. Phytother Res, 2023, 37:295-309.
|